Evidence for accelerated colorectal adenoma-carcinoma progression in MUTYH-associated polyposis?

Gut

Volumn 61, Issue 5, 2012, Pages 734-738

  Nieuwenhuis, M H ^a   Vogt, S ^b   Jones, N ^c   Nielsen, M ^d   Hes, F J ^d   Sampson, J R ^c   Aretz, S ^b   Vasen, H F A ^a,d  

^a Foundation for the Detection of Hereditary Tumours   (Netherlands)

^b UNIVERSITY OF BONN   (Germany)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHILD; COLON CARCINOGENESIS; COLON RESECTION; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; FOLLOW UP; GASTROINTESTINAL POLYPOSIS; GENE; GENE MUTATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MUTYH ASSOCIACTED POLYPOSIS; MUTYH GENE; PRIORITY JOURNAL; SCHOOL CHILD;

ADENOMA; ADOLESCENT; ADULT; AGED; CHILD; COLECTOMY; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA GLYCOSYLASES; FEMALE; FOLLOW-UP STUDIES; GENETIC MARKERS; GERM-LINE MUTATION; HUMANS; INTESTINAL POLYPOSIS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; REOPERATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859606763     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.229104     Document Type: Article

References (24)

1. Al-tassan N, Chmiel NH, Maynard J, et al. Inherited variants of MYH associated with somatic G: C-T: a mutations in colorectal tumors. Nat Genet 2002;30:227-32.
2. Lubbe SJ, Di Bernardo MC, Chandler IP, et al. Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol 2009;27:3975-80.
3. Aretz S, Uhlhaas S, Goergens H. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer 2006;119:807-14. (Pubitemid 44051443)
4. Vogt S, Jones N, Christian D, et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology 2009;137:1976-85.
5. Buecher B, Baert-Desurmont S, Leborgne J, et al. Duodenal adenocarcinoma and Mut Y human homologue-associated polyposis. Eur J Gastroenterol Hepatol 2008;20:1024-7.
6. Jenkins M, Croitoru M, Monga N, et al. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol Biomarkers Prev 2006;15:312-14. (Pubitemid 43342180)
7. Tenesa A, Campbell H, Barnetson R, et al. Association of MUTYH and colorectal cancer. Br J Cancer 2006;95:239-42. (Pubitemid 44050924)
8. Lindor NM. Hereditary colorectal cancer: MYH-associated polyposis and other newly identified disorders. Best Pract Res Clin Gastroenterol 2009;23:75-87.
9. Jones N, Vogt S, Nielsen M, et al. Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH. Gastroenterology 2009;137:489-94.
10. Vasen HF, Moeslein G, Alonso A, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008;57:704-13. (Pubitemid 351579987)
11. Terdiman JP. MYH-associated disease: attenuated polyposis of the colon is only part of the story [editorial]. Gastroenterology 2009;137:1883-6.
12. Nielsen M, Franken PF, Reinards TH, et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet 2005;42:e54.
13. Jones S, Emmerson P, Maynard J, et al. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G: C>T: a mutations. Hum Mol Genet 2002;11:2961-7.
14. Nielsen M, Joerink-van de Beld MC, Jones N, et al. Analysis of MUTYH genotypes and colorectal phenotypes in patients with MUTYH-associated polyposis. Gastroenterology 2009;136:471-6.
15. Caspari R, Friedl W, Mandl M, et al. Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer. Lancet 1994;343:629-32. (Pubitemid 24087806)
16. Knudsen AL, Bulow S, Tomlinson I, et al. Attenuated familial adenomatous polyposis (AFAP): results from an international collaborative study. Colorectal Dis 2010;12: e243-9.
17. Cleary SP, Cotterchio M, Jenkins MA, et al. Germline MutY Human homologue mutations and colorectal cancer: a multisite caseecontrol study. Gastroenterology 2009;136:1251-60.
18. Vasen HF, Abdirahman M, Brohet R, et al. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology 2010;138:2300-6.
19. Casper M, Plotz G, Juengling B, et al. Adenoma development in a patient with MUTYH-associated polyposis (MAP): new insights into the natural course of polyps development. Dig Dis Sci 2010;55:1711-15.
20. Lefevre JH, Colas C, Coulet F, et al. MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversions. Fam Cancer 2010;9:589-94.
21. Nielsen M, de Miranda NF, van Puijenbroek M, et al. Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas. BMC Cancer 2009;15:184.
22. Boparai KS, Dekker E, Van Eeden S, et al. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology 2008;135:2014-18.
23. Leite JS, Isidro G, Martins M, et al. Is prophylactic colectomy indicated in patients with MYH-associated polyposis? Colorectal Dis 2005;7:327-31. (Pubitemid 40894859)
24. Ferrández A, Navarro M, Díez M, et al. Risk factors for advanced lesions undetected at prior colonoscopy: not always poor preparation. Endoscopy 2010;42:1071-6.